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AbstrACt
Introduction Nutritional intervention and prevention of 
malnutrition is significantly important for patients with 
upper gastrointestinal oesophageal, pancreatic and 
gastric cancer. However, there is limited information 
regarding nutritional status, and perioperative nutritional 
interventions that patients receive when undergoing 
curative surgery.
Methods and analysis Patients diagnosed with upper 
gastrointestinal cancer, planned for curative intent 
resection across 27 Australian hospitals will be eligible to 
participate in this point prevalence study. The primary aim 
is to determine the prevalence of malnutrition in patients 
with upper gastrointestinal cancer at the time of surgery 
using subjective global assessment. Secondary aims 
are to determine the type and frequency of perioperative 
nutritional intervention received, the prevalence of 
clinically important weight loss and low muscle strength, 
and to investigate associations between the use of an 
evidence- based nutrition care pathway or protocol for the 
nutritional management of upper gastrointestinal surgical 
oncology patients and malnutrition prevalence. Data 
collection will be completed using a purpose- built data 
collection tool.
Ethics and dissemination Ethical approval was granted 
in May 2019 (LNR/51107/PMCC-2019). The design and 
reporting of this study comply with the Strengthening 
the Reporting of Observational Studies in Epidemiology 
checklist for reporting of observational cohort studies. 
Findings will be published in peer- reviewed scholarly 
journals and presented at relevant conferences. Results 
will assist in defining priority areas for research to improve 
patient outcomes.
INtroduCtIoN
Patients with oesophageal, gastric and pancre-
atic cancer, known as upper gastrointestinal 
(UGI) cancer, can experience significant 
nutritional issues. Malnutrition is an inde-
pendent risk factor for increased mortality, 
surgical complications, length of stay 
(LOS) and decreased chemo/radiotherapy 
tolerance and quality of life (QOL).1–3 Rates 
of malnutrition in patients with UGI cancer 
are among the highest of all tumour groups, 
reported to be between 40% and 80% at any 
given time post diagnosis.4–9 However, there is 
limited prospective data regarding the nutri-
tional status of patients with UGI cancer at 
the time of curative intent surgery using vali-
dated assessment methods.
Practice guidelines recommend early and 
sustained nutritional intervention for patients 
with cancer who are at high risk of nutri-
tional decline.2 In major abdominal surgery, 
perioperative optimisation is strongly recom-
mended.3 However, despite the increasing 
body of evidence regarding the importance 
of prevention and treatment of malnutrition, 
there are no published evidence- based prac-
tice guidelines for nutritional intervention in 
UGI cancers specifically.10 Robust evidence to 
support perioperative nutritional interven-
tions specific to this patient group is not avail-
able in the current literature. Subsequently, 
significant variation in the self- reported nutri-
tional practices of dietitians and surgeons 
have been previously demonstrated,11 12 and 
strengths and limitations of this study
 ► This is the largest study to prospectively conduct 
nutritional assessment of patients with upper gas-
trointestinal cancer at the time of surgery, using val-
idated assessment methods.
 ► The unique dataset will provide a detailed snapshot 
of nutritional status and associated clinical and ser-
vice delivery outcomes.
 ► Limitations of the study include potential variations 
in data collection procedures; however, all sites will 
undergo training and follow standardised protocols 
to ensure reliable results.
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clinical screening and assessment programmes are often 
inadequate.13 While some research is being undertaken 
to understand the nutrition support received for patients 
with head and neck, and oesophageal tumours,14 there 
is a significant lack of information regarding the periop-
erative nutritional interventions that patients with UGI 
cancer receive when undergoing curative surgery. Further 
exploration of current nutritional status, nutritional 
practices and associated surgical outcomes is required 
to inform the development of clinical trials to optimise 
nutrition management, which will ultimately lead to the 
development of evidence- based practice guidelines. The 
Nutritional Outcomes of patients Undergoing Resection 
for upper gastroIntestinal cancer in AuStralian Hospitals 
(NOURISH) Point Prevalence Study aims to ascertain 
this important information.
The primary aims are as follows:
1. To determine the prevalence of malnutrition at the 
time of surgery in patients undergoing resection for 
UGI cancer using subjective global assessment (SGA).
2. To determine the type and frequency of perioperative 
dietetics and nutritional intervention received.
Secondary aims are as follows:
1. To determine the prevalence of clinically important 
weight loss (>5%) and low muscle strength from hand 
grip strength dynamometry.
2. To investigate associations between nutritional status, 
dietetics intervention and surgical outcomes (LOS, 
discharge destination, surgical complications).
3. To investigate associations between the use of an 
evidence- based nutrition care pathway or protocol for 
the nutritional management of UGI surgical oncology 
patients and malnutrition prevalence.
MEthods
study design and setting
This is an observational point prevalence study that 
will be conducted at 27 tertiary metropolitan hospitals 
across Victoria, New South Wales, Queensland, South 
Australia, Western Australia and Australian Capital Terri-
tory, Australia (participating sites can be viewed in online 
supplementary file 1). The minimum recruitment period 
will be 4 months (or minimum 10 participants per site), 
representing at least one- third of the yearly UGI cancer 
cohort undergoing surgery at each site. Recruitment 
commenced on the 2 September 2019, and data collec-
tion will be completed by 30 June 2020.
Inclusion and exclusion criteria
Patients will be considered eligible for participation if 
they are 18 years or older and are inpatients after cura-
tive intent UGI cancer surgery, including those who have 
received or not received neoadjuvant therapy. Eligible 
surgery types include gastrectomy (subtotal, total, partial), 
pancreatectomy (total, distal, partial, pancreaticoduo-
denectomy), oesophagectomy or gastro- oesophagectomy. 
Patients must be able to consent to participation via 
English language communication, or with the presence 
of an interpreter. Patients will be excluded if they under-
went palliative surgery, are unable to provide consent or 
participate in assessment, are taking intravenous opioids 
at the time of consent, are unaware of their diagnosis of 
malignancy, or assessment of nutritional status does not 
occur within 7 days of surgery.
outcome measurements and data collection
Figure 1 outlines the study data collection schedule. Site 
investigators will conduct a nutritional assessment and 
survey of the participants at a single timepoint within 7 
days of their UGI cancer surgery, to accurately reflect 
nutritional status at the time of surgery. Data will also 
be collected from the medical record during the partici-
pant’s hospital admission, which will include information 
regarding dietetics intervention, nutritional intake and 
surgical outcomes. All site investigators are experienced 
clinical dietitians who are trained in completion of all 
associated components of nutrition assessment. Further-
more, all site investigators will receive training by the 
research team via webinar prior to study commencement 
to ensure standard practices and reliability in data collec-
tion and entry across sites, as per previous large preva-
lence studies.8 Site principal investigators (PI) will also 
participate in a questionnaire pertaining to site- specific 
practices for the nutritional management of UGI surgical 
oncology patients.15 16 The data collection tool can be 
viewed in online supplementary file 2. Table 1 outlines 
the methods and modes of data collection for patient 
data.
Demographic characteristics
Baseline demographic characteristics will include age, 
sex, primary language spoken, usual social situation, 
distance from hospital and if identified from a Culturally 
and Linguistically Diverse or Aboriginal and Torres Strait 
Islander background.
Tumour and surgical characteristics
Tumour characteristics will include date of diagnosis, 
tumour site, type and pathological staging from recorded 
biopsy results at time of surgery, as per defined tumour 
node metastasis staging system.17 Details regarding 
neoadjuvant chemo/radiotherapy receipt and comple-
tion will also be documented. The surgical procedure 
details including date, type and surgical technique used 
will also be recorded.
Nutritional status
Anthropometry and body mass index
Weight will be measured using standard hospital weighing 
equipment on the day of nutritional assessment within 
7 days of surgery, and within 2 days prior to hospital 
discharge. Investigators will also determine the presence 
of oedema and will record estimated dry weight if oedema 
is present. If patients are unable to be weighed within 7 
days of surgery, they will be asked to recall their weight 
from the week prior to surgery. Patients will also be asked 
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Figure 1 Study data collection schedule.
to recall and report their weight history from 2 weeks, 
1, 3, 6 and >6 months prior to their surgery. Weight will 
be recorded to the nearest 0.5 kg, and percentage (%) 
weight loss will be calculated to the nearest 0.1% for each 
timepoint. Percentage weight loss will be used as part of 
the nutritional assessment, as well as to report on the 
prevalence of clinically important weight loss >5%, as per 
secondary aims. Height will be measured using a wall- 
mounted stadiometer or can be patient reported, to the 
nearest centimetre. Patient reported weight and height 
history has been demonstrated to be reliable against 
actual history.18 If patients cannot recall their weight or 
height and are unable to be measured, the medical history 
will be checked for this information, and if unavailable it 
will be marked as missing data. Body mass index (BMI) 
will be calculated using the following formula: BMI (kg/
m2)=weight (kg)/height squared (m2).19 BMI will be used 
to assess if patient fulfils the international definition of 
malnutrition, as specified below.
Assessment of nutritional status
Nutritional status will be evaluated using the SGA, which 
has been validated as a nutritional assessment tool in 
hospitalised populations, including oncology patients.2 20 
It consists of: (1) historical components: weight history, 
dietary intake changes, gastrointestinal symptom history 
and reported activities and function. (2) Physical assess-
ment: muscle and fat loss, and fluid accumulation.
The clinician provides an overall subjective assessment 
rating, based on the above SGA components: (1) well 
nourished, (2) mild/moderate or suspected malnutri-
tion or (3) severe malnutrition. A standardised protocol 
will be adopted for completion of the SGA across all 
sites. Further details of the components of the SGA are 
outlined in the data collection tool (online supplemen-
tary file 2).
The dietitian will also assess for malnutrition using 
The International Classification of Diseases, 10th Revi-
sion Australian modification (ICD-10- AM) classification 
for malnutrition, to ensure that the appropriate dietetics 
intervention is provided in the clinical setting per Austra-
lian malnutrition coding procedures.21 Based on the 
components of the SGA, ICD-10- AM defines malnutri-
tion as BMI <18.5 kg/m2 or unintentional loss of weight 
(5%–9%) with evidence of suboptimal intake resulting 
in moderate loss of subcutaneous fat and/or moderate 
muscle wasting.
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Table 1 Methods and modes of patient data collection
Outcome measurement
Face to face interview 
with patient
Data collection from 
medical records
Demographic, tumour and surgical characteristics X X
Nutritional status
Subjective global assessment X   
International Classification of Diseases Australian Modification Malnutrition 
Diagnosis
X   
Height X X*
Weight (baseline and end of hospital admission) X X*
Body mass index X   
Weight history X X*
Muscle strength using hand grip strength dynamometer X   
Dietetics and nutritional intervention
Inpatient dietetics intervention   X
Prior dietetics intervention X X
Postdischarge dietetics intervention   X
Prior nutritional intervention X   
Nutritional intake during hospital admission   X
Surgical outcomes and length of stay   X
*Check baseline information postpatient interview if required.
Dietetics intervention
Prior dietetics intervention
Participants will be asked to recall if they have seen a 
dietitian prior to surgery, since their cancer diagnosis. If 
patients have seen a dietitian during this time, the loca-
tion and timing of the last contact with the dietitian will 
be recorded if known.
Inpatient dietetics intervention
The day of first dietetics contact with the patient postop-
eratively will be recorded. Dietetics intervention provided 
for the first 10 days following surgery will be documented, 
including dietary counselling, enteral nutrition (EN), 
parenteral nutrition (PN), oral nutrition support (ONS) 
or no nutrition intervention. The hospital ‘diet codes’ 
of Nil by Mouth, Clear Fluids, Free Fluids, Pureed or 
Minced, Light ward diet, Full Ward Diet, Soft Ward Diet 
will also be recorded. At the end of the patient’s inpatient 
admission the total number of contacts by the dietitian 
will be calculated.
Postdischarge dietetics intervention
Dietetics follow- up arrangements for each patient on 
discharge will be documented including timeframe 
for follow- up (within 2 weeks; 2–4 weeks; 4–8 weeks; >8 
weeks) and location of service (on site specialist UGI 
clinic; on site general clinic; community health service 
dietitian; private dietitian). The hospital ‘diet code’ on 
discharge, and the provision of ONS and EN will be docu-
mented, including the percentage of estimated energy 
and protein requirements met by ONS and EN.
Nutritional intervention
Participants will be asked to recall if they have received 
any preoperative nutritional advice from their surgeon, 
oncologist, general practitioner or other healthcare 
professional; and what advice was provided. Participants 
will also be asked to recall if they have been receiving any 
nutritional support including ONS drinks, immunonutri-
tion drinks, carbohydrate loading drinks, EN or PN prior 
to surgery.
Nutritional intake
Patients will be asked to recall any decreases in their 
food intake before surgery by estimating the decrease 
compared with normal, recorded as ≥75%, ≤75%, ≤50%, 
≤25% of their usual intake. Postoperative estimated 
energy requirements (EER) and estimated protein 
requirements (EPR) at the time of surgery will be deter-
mined by the site dietitian using prediction equations. 
The proportion of EER and EPR met since last dietitian 
review (ranges <20%, 20%–40%, 40%–60%, 60%–80%, 
80%–100%), as calculated by the dietitian by determining 
daily intake against EER and EPR during clinical reviews 
will be documented for the first 10 days postoperatively. 
This will provide information regarding compliance and 
adequacy of nutrition intervention prescribed.
Muscle strength
Low muscle mass is a key component of malnutrition diag-
nosis, and a strong determinant of outcomes in patients 
with cancer undergoing surgery.22 The use of pre- existing 
diagnostic CT scans to determine skeletal muscle index 
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in oncology patients, at the level of lumbar spine 3 (L3) 
is well validated. However, due to resource constraints 
of this study with 27 recruitment sites, we are not able 
to perform objective analysis of muscle mass using CT 
or other measures. Muscle strength measurement can 
be used as a surrogate measurement of muscle mass, in 
the absence of an objective measure.22 Muscle strength 
will be measured using hand dynamometers as per the 
methodology of the American Society of Hand Thera-
pists (ASHT), which is considered the gold standard.23 
Sites will be provided with a training package and a stan-
dard protocol to follow ASHT methodology, to ensure 
reliability. Assessment of hand grip strength by different 
assessors can be considered interchangeable, if asses-
sors follow the same protocol.23 The Australian and New 
Zealand Society for Sarcopenia and Frailty Research and 
the newly released Global Leadership Initiative on Malnu-
trition criteria suggested muscle strength cut- off values of 
<20 kg for women and <30 kg for men for the diagnosis of 
sarcopenia.22 The Asian Working Group for Sarcopenia 
adapted cut- off values of <18 kg for women and <26 kg for 
men will be used for participants of Asian background.24 
The mean value of both left and right hands will be 
recorded, and the highest value will be used for muscle 
function analysis as per the ASHT methodology.
Surgical outcomes and LOS
LOS will be calculated once the patient is discharged 
from the acute surgical admission. Discharge destina-
tion (home, aged care facility, inpatient rehabilitation, 
death) will be recorded. Incidence of surgical compli-
cations known to be impacted by malnutrition will be 
recorded from the medical file as documented by the 
surgical team, including presence of surgical site/wound 
infection, sepsis, anastomotic leak, fistula, respiratory 
tract infection, pneumonia, pressure injury, wound dehis-
cence, gastroparesis, chyle leak, return to theatre, abdom-
inal collection or ileus.
Site Specific Dietetics Practices Questionnaire
Site PI dietitians will be invited to participate in a purpose 
built, online questionnaire at the commencement of 
the study on behalf of their site. Information regarding 
current site- specific practices for the nutritional manage-
ment of UGI surgical oncology patients, including the 
use of evidence- based protocols or pathways such as 
Enhanced Recovery After Surgery (ERAS), and provi-
sion of inpatient and outpatient perioperative dietetics 
services will be collected. Results of the questionnaire will 
be linked with patient data to investigate associations to 
address the secondary aims of the study. The site ques-
tionnaire can be viewed as online supplementary file 3.
statistical considerations
Estimated sample size
Sample size is pragmatic based on patients presenting to 
the sites within the above timeframes in 2017/2018. Total 
recruitment sample size is expected to be a minimum of 
200 participants. Assuming malnutrition prevalence is 
50%, the corresponding 95% CI is (43% to 57%), that is, 
a precision of ±7%, which is considered appropriate for 
the primary outcome. Achieved precision will be higher if 
the prevalence is closer to 0% or to 100%.
Statistical analysis
The primary aim, estimating the proportion of patients 
with malnutrition, will be obtained from the observed 
point prevalence with exact 95% CIs. Descriptive statistics 
will be used to describe baseline characteristics of partic-
ipants, nutritional status measurements and nutritional 
intervention received. For normally distributed data, 
means and SDs will be used; with medians and IQRs for 
non- normally distributed data. Counts and percentages 
will also be used as appropriate. Associations between 
nutritional status, use of evidence- based nutrition care 
pathways/procedures and surgical outcomes will be 
investigated using multiple logistic regression analysis, 
and will also account for tumour type and stage (1–4), 
age and sex. LOS will be treated as time to event and anal-
ysed univariately with Kaplan- Meier and the log- rank test. 
Subsequently a Cox proportional hazard analysis will be 
used to adjust for tumour type and stage, age and sex. 
The proportional hazards assumption will be assessed by 
a global test of the residuals. Responses to the site- specific 
practices questionnaire will be presented descriptively 
using means and SDs or medians and IQR and counts 
and percentages as appropriate to the format of each 
question. Free text responses will be summarised. The 
statistical package SPSS (V.24 or newest release (licensed 
to the University of Melbourne, Chicago, Illinois, USA)) 
will be used for quantitative data analysis.
Patient and public involvement
Patients/the public were not involved in the design of 
this study, however patient feedback from a previous 
study was used to design the data collection tool. Each 
patient will be made aware of their individual nutrition 
assessment. The high number of sites and participants 
makes it impractical to provide group results to patients 
individually.
EthICs ANd dIssEMINAtIoN
Approval
This project received full ethical approval under the 
Australian National Mutual Acceptance ethical review 
scheme by The Peter MacCallum Cancer Centre Ethics 
Committee in May 2019 (LNR/51107/PMCC-2019). 
Ethics and governance approval at each participating 
hospital will also be obtained prior to commencement 
at each site (online supplementary file 1). The study will 
be conducted as per the National Health and Medical 
Research Council (NHMRC) National Statement on 
Ethical Conduct in Human Research (2007 and updates) 
and the World Medical Association Declaration of 
Helsinki (2013 and updates). The design and reporting of 
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this study complies with the Strengthening the Reporting 
of Observational Studies in Epidemiology checklist for 
reporting of observational cohort studies.25
Informed consent
Study dietitians will identify and approach eligible 
patients prior to, or at the time of surgical admission 
by screening surgical procedure lists and liaising with 
surgical and nursing staff. Patients will be provided with 
a study patient information statement (PIS), and will be 
given a minimum of 24 hours to read it. Study dietitians 
will also explain the study verbally and answer questions. 
The patient will then be asked to provide verbal consent 
for participation, once they can confirm that they have 
read and understood the PIS and what their participation 
will involve. Consent will be obtained and documented 
in accordance with international good clinical practice 
(GCP) requirements, and all study personnel will undergo 
appropriate training. Patients will be asked to re- confirm 
verbal consent prior to the physical assessment compo-
nent of the SGA, the hand grip strength test, as well as 
re- confirm consent for data collection from their medical 
record. Participants will also be informed that they may 
withdraw their consent at any time. Both participants 
and non- participants will receive standard dietetics care 
during the study.
data collection and management
Study data will be collected and managed via a purpose- 
built, secure electronic data collection tool (REDCap, 
hosted at The University of Melbourne), which will be 
used for data collection and entry.15 16 Participant data 
will be anonymised using unique study identification 
numbers prior to data entry into the REDCap database. 
Only the coordinating researcher (ID) will have access to 
the full de- identified dataset, and each site will have access 
to their own data. If paper copies of the data collection 
form are used, they will also be anonymised, and stored in 
the locked offices of the dietetics department at each site. 
The principal investigator at each site will be responsible 
for the management and security of data. The site- specific 
practices questionnaire will be completed online only via 
the project’s secure REDCap survey link by the principal 
investigator at each site. Data will be kept for 5 years 
from the completion of the project, in accordance with 
the NHMRC National Statement on Ethical Conduct in 
Human Research (2007 and updates) and international 
GCP requirements.
results dissemination
Findings from this study to be published in peer- reviewed 
scholarly journals and presented at relevant conferences 
national and internationally. Any published data will be 
aggregated and de- identified. The study is being under-
taken in part- fulfilment of the Doctor of Philosophy 
(PhD) of the coordinating researcher (ID) at The Univer-
sity of Melbourne, Melbourne, Australia.
dIsCussIoN
Malnutrition is a significant problem in UGI cancer, 
with up to 80% of patients reporting more than 5% or 
10% wt loss at initial presentation.9 26 27 Nutrition support 
should be commenced as early as possible and continued 
throughout the perioperative period.3 However, there is 
limited evidence regarding the optimal methods of nutri-
tional intervention, leading to inconsistencies in clin-
ical practice by members of the multidisciplinary team, 
including dietitians.11–13 28
Further research is required to determine the most 
effective intervention methods to optimise nutrition, 
QOL and surgical outcomes, to develop evidence- based 
practice guidelines. The relatively low incidence of 
UGI cancer amenable to curative intent surgery makes 
it difficult to conduct high quality, effective nutritional 
research, and this could be one of the reasons why clin-
ical nutrition trials in this high- risk patient group are 
significantly lacking in Australia and internationally. 
A thorough understanding of the nutritional needs 
of the UGI surgical oncology population and current 
practices in relation to current best available evidence 
is required to inform the development of clinical trials, 
and for the development of evidence- based practice 
guidelines.10 However, current data regarding the prev-
alence of malnutrition, perioperative nutrition and 
dietetics practices, and clinical outcomes is inadequate. 
The results of this study will inform the current evidence 
base in UGI surgical oncology nutrition by providing a 
robust cross- sectional dataset of malnutrition prevalence 
rates obtained using validated assessment methods, and 
a unique detailed understanding of the perioperative 
dietetics and nutritional intervention received by patients 
across 27 Australian tertiary hospitals. The results of this 
study will identify priority areas for the design of prospec-
tive research and quality improvement, ultimately aiming 
to improve the outcomes of patients undergoing resec-
tion for UGI cancer.
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